Stem Cell Microvesicles: Potential Tools for Retinal Regeneration
干细胞微泡:视网膜再生的潜在工具
基本信息
- 批准号:7360347
- 负责人:
- 金额:$ 23.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:AnteriorAqueous HumorBlood PlateletsBromodeoxyuridineCell Differentiation processCell membraneCellsCiliary BodyClassComplexConditionCuesEGF geneES Cell LineElectron MicroscopyEndothelial CellsEnvironmentEpitheliumEyeFGF2 geneFibroblast Growth Factor 2GoalsGreen Fluorescent ProteinsHematopoieticHumanImmunohistochemistryIn VitroInjection of therapeutic agentInvertebratesLabelLeadLearningLipidsLiquid ChromatographyLymphocyteMammalsMass Spectrum AnalysisMediatingMediator of activation proteinMembrane ProteinsMessenger RNAMicroRNAsMicroarray AnalysisMolecularMultipotent Stem CellsMusNatural regenerationPlayPopulationProteinsRNARangeReportingRetinaRetinalReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSmall RNAStem cell transplantStem cellsSupporting CellTestingTimeTranscriptTransfer RNATranslationsVertebratesVesicleWestern Blottinganterior chamberaqueouscell typedayembryonic stem cellextracellulargranulocyteimmunocytochemistryin vivointercellular communicationmigrationnanoneoplastic cellnestin proteinnovelparacrineparticlepluripotencyprogenitorprogramsresearch studyretinal progenitor cellretinal regenerationsizestemstem cell fatetool
项目摘要
DESCRIPTION (provided by applicant): The retina in lower vertebrates shows a remarkable regenerative ability that is lost in mammals. Multipotent progenitor cells, that are capable of differentiating into a variety of retinal cell types, have been isolated from the ciliary margin and retina of mammalian eyes. Despite their presence, these progenitor cells are normally quiescent and unable to regenerate damaged retina. This proposal will investigate the ability of microvesicles, released from mouse embryonic stem cells, to reactivate mouse retinal progenitor cells. The long term goal of this project is to discover novel ways of reactivating quiescent progenitor cell populations in the human eye, so that regeneration of damaged retina may be possible.
Microvesicles are plasma-membrane particles that are released into the extracellular environment. Very recently, microvesicles have been reported from embryonic stem cells cultured in vitro. Our preliminary results show that these embryonic stem cell microvesicles contain RNA and protein. Most interestingly, they contain a specific class of RNA molecules called microRNAs, which are potent regulators of translation. Microvesicles may serve a role in intercellular communication in one of several manners. They may transfer microRNAs, mRNAs, or proteins to cells. Alternatively they can signal cells through surface proteins found on microvesicles.
Our first aim is to characterize the RNA and protein contents of mouse embryonic stem cell microvesicles to look for candidates that might alter stem cell programming. We will use microarray analysis and qRT-PCR for mRNA and microRNA profiling, and mass spectrometry, Western blot analysis, and immunocytochemistry for protein profiling. We will also explore in Aim I the ability of these microvesicles to directly transfer RNA or protein to cells in vitro. Our second aim is to determine if these microvesicles can activate the quiescent stem cell population found in the ciliary margin and retina of mouse eyes. We will inject microvesicles into the aqueous, vitreous, and subretinal space of mice and look for increased proliferation of stem cells with BrDU- labeling. Our final aim is to look for endogenous microvesicles in the aqueous and vitreous and also to characterize them using microarray profiling, qRT-PCR, mass spectrometry, Western blot analysis, immunocytochemistry, and electron microscopy. The information generated in this proposal will not only lead to an increased understanding of the role that extrinsic mRNA, microRNAs, and proteins play in determining stem cell fate, but may also identify microvesicles as novel endogenous signaling factors in the eye, and possibly contributing to the stem cell niche.
描述(由申请人提供):低等脊椎动物的视网膜显示出哺乳动物所丧失的显着的再生能力。已经从哺乳动物眼睛的睫状缘和视网膜中分离出能够分化成多种视网膜细胞类型的多能祖细胞。尽管存在,这些祖细胞通常处于静止状态,无法再生受损的视网膜。该提案将研究小鼠胚胎干细胞释放的微泡重新激活小鼠视网膜祖细胞的能力。该项目的长期目标是发现重新激活人眼中静止祖细胞群的新方法,从而使受损的视网膜再生成为可能。
微泡是释放到细胞外环境中的质膜颗粒。最近,据报道体外培养的胚胎干细胞产生微泡。我们的初步结果表明这些胚胎干细胞微泡含有RNA和蛋白质。最有趣的是,它们含有一类称为 microRNA 的特定 RNA 分子,它们是翻译的有效调节因子。微泡可以通过多种方式之一在细胞间通讯中发挥作用。它们可以将 microRNA、mRNA 或蛋白质转移到细胞中。或者,它们可以通过微泡上的表面蛋白向细胞发出信号。
我们的首要目标是表征小鼠胚胎干细胞微泡的 RNA 和蛋白质含量,以寻找可能改变干细胞编程的候选者。我们将使用微阵列分析和 qRT-PCR 进行 mRNA 和 microRNA 分析,并使用质谱、蛋白质印迹分析和免疫细胞化学进行蛋白质分析。我们还将在目标 I 中探索这些微泡在体外直接将 RNA 或蛋白质转移到细胞的能力。我们的第二个目标是确定这些微泡是否可以激活小鼠眼睛睫状缘和视网膜中发现的静止干细胞群。我们将微泡注射到小鼠的房水、玻璃体和视网膜下腔中,并通过 BrDU 标记寻找干细胞增殖的增加。我们的最终目标是寻找房水和玻璃体中的内源性微泡,并使用微阵列分析、qRT-PCR、质谱、蛋白质印迹分析、免疫细胞化学和电子显微镜对其进行表征。该提案中产生的信息不仅会加深人们对外源 mRNA、microRNA 和蛋白质在决定干细胞命运中所起的作用的理解,而且还可能将微泡识别为眼睛中新型的内源性信号传导因子,并可能有助于干细胞生态位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORA B FARBER其他文献
DEBORA B FARBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORA B FARBER', 18)}}的其他基金
Stem Cell Microvesicles: Potential Tools for Retinal Regeneration
干细胞微泡:视网膜再生的潜在工具
- 批准号:
7534779 - 财政年份:2007
- 资助金额:
$ 23.3万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6929014 - 财政年份:2003
- 资助金额:
$ 23.3万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
7084565 - 财政年份:2003
- 资助金额:
$ 23.3万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6766784 - 财政年份:2003
- 资助金额:
$ 23.3万 - 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
- 批准号:
6702942 - 财政年份:2003
- 资助金额:
$ 23.3万 - 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
- 批准号:
6417480 - 财政年份:2001
- 资助金额:
$ 23.3万 - 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
- 批准号:
6525356 - 财政年份:2001
- 资助金额:
$ 23.3万 - 项目类别:
相似海外基金
The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
- 批准号:
10667863 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Regulation of Intraocular Pressure via a Novel Adjustable Glaucoma Drainage Device
通过新型可调节青光眼引流装置调节眼压
- 批准号:
10735637 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Racial disparities of open angle glaucoma: A study of mitochondria and oxidative stress in human trabecular meshwork
开角型青光眼的种族差异:人类小梁网线粒体和氧化应激的研究
- 批准号:
10735655 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma
乳腺癌、胰腺癌和多发性骨髓瘤的多模式液体活检早期评估
- 批准号:
10763336 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Anatomical and functional imaging of the conventional outflow pathway
传统流出通道的解剖和功能成像
- 批准号:
10752459 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别: